Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
Meenakshi Vachher(University of Delhi), Archana Burman(University of Delhi), Taruna Arora(Amgen (United States)), Bhupender Kumar(Alexandra Hospital), Savita Bansal(University of Delhi), Nalini Moza Wali(University of Delhi), Sandeep Yadav(Shri Venkateshwara University)
Cited by 11
Related Papers
AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma
|Molecular Cancer Therapeutics|2015|99
Visceral fat: A key mediator of NAFLD development and progression
|Human Nutrition & Metabolism|2023|58
Subjective sleep problems in young women suffering from premenstrual dysphoric disorder
|North American Journal of Medical Sciences|2012|40
Alcoholic Binge and Nontraumatic Rhabdomyolysis: A Case Report
|Annals of Clinical Case Reports|2017|20